刘雪莹;党玉洁;秦莹莹;

• 1:山东大学生殖医学研究中心国家辅助生殖与优生工程技术研究中心生殖内分泌教育部重点实验室山东省生殖医学重点实验室山东省生殖健康临床医学研究中心山东大学附属生殖医院

摘要(Abstract)：

生长激素(GH)在生殖医学领域的应用已有30余年。目前,许多研究关注GH可否改善体外助孕妊娠结局,在卵巢低反应、胚胎质量差、反复胚胎移植失败以及薄型子宫内膜等人群中的应用均取得了一定的研究进展。本文对GH在辅助生殖应用中的作用机制、对妊娠结局的影响、应用剂量及方式等的研究进展进行综述,以期为GH的临床应用提供参考。

关键词(KeyWords)： 生长激素;辅助生殖;卵巢低反应;反复胚胎种植失败;卵母细胞

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划(No:2017YFC1001100);; 国家自然科学基金(No:81701406);; 山东省医药卫生科技发展计划项目(No:202005010520,No:202005010523)

作者(Authors): 刘雪莹;党玉洁;秦莹莹;

DOI: 10.13283/j.cnki.xdfckjz.2021.11.014

参考文献(References)：

• [1]Ipsa E,Cruzat VF,Kagize JN,et al.Growth hormone and insulin-like growth factor action in reproductive tissues[J].Front Endocrinol(Lausanne),2019,10:777
• [2]Zhou P,Baumgarten SC,Wu Y,et al.IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells[J].Mol Endocrinol,2013,27(3):511-523
• [3]Li Y,Liu H,Yu Q,et al.Growth hormone promotes in vitro maturation of human oocytes[J].Front Endocrinol (Lausanne),2019,10:485
• [4]Weall BM,Al-Samerria S,Conceicao J,et al.A direct action for GH in improvement of oocyte quality in poor-responder patients[J].Reprod,2015,149(2):147-154
• [5]Gong Y,Zhang K,Xiong D,et al.Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders:a randomized controlled trial[J].Reprod Biol Endocrinol,2020,18(1):91
• [6]Cui N,Li AM,Luo ZY,et al.Effects of growth hormone on pregnancy rates of patients with thin endometrium[J].JEndocrinol Invest,2019,42(1):27-35
• [7]Wang XM,Jiang H,Zhang WX,et al.The effects of growth hormone on clinical outcomes after frozen-thawed embryo transfer[J].Int J Gynaecol Obstet,2016,133(3):347-350
• [8]Boza A,Oguz SY,Misirlioglu S,et al.Utilization of the Bologna criteria:a promise unfulfilled?A review of published and unpublished/ongoing trials[J].Fertil Steril,2018,109(1):104-109.e2
• [9]Cozzolino M,Cecchino GN,Troiano G,et al.Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles:a systematic review and meta-analysis[J].Fertil Steril,2020,114(1):97-109
• [10]Yang P,Wu R,Zhang H.The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI:a meta-analysis of randomized controlled trials[J].Reprod Biol Endocrino,2020,18(1):76
• [11]Dakhly DMR,Bassiouny YA,Bayoumi YA,et al.The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization:randomized control trial[J].Eur J Obstet Gynecol Reprod Biol,2018,228:161-165
• [12]Li J,Chen Q,Wang J,et al.Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development?A randomized controlled trial[J].BMC pregnancy and childbirth,2020,20(1):310
• [13]Liu X,Bai H,Xie JE,et al.Growth hormone co-treatment on controlled ovarian stimulation in normal ovarian response women can improve embryo quality[J].Gynecol Endocrinol,2019,35(9):787-791
• [14]Kasius A,Smit JG,Torrance HL,et al.Endometrial thickness and pregnancy rates after IVF:a systematic review and meta-analysis[J].Hum Reprod Update,2014,20(4):530-41
• [15]Yang JY,Li H,Lu N,et al.Influence of growth hormone supplementation in patients with thin endometrium undergoing frozen embryo transfer[J].Reproductive and Developmental Medicine,2019,3(1):49
• [16]Altmae S,Mendoza-Tesarik R,Mendoza C,et al.Effect of growth hormone on uterine receptivity in women with repeated implantation failure in an oocyte donation program:a randomized controlled trial[J].J Endocr Soc,2018,2(1):96-105
• [17]Chen Y,Liu F,Nong Y,et al.Clinical efficacy and mechanism of growth hormone action in patients experiencing repeat implantation failure[J].Can J Physiol Pharmacol,2018,96(9):929-932
• [18]Tesarik J,Galán-Lázaro M,Conde-López C,et al.The effect of GH administration on oocyte and zygote quality in young women with repeated implantation failure after IVF[J].Front Endocrinol(Lausanne),2020,11:519572
• [19]Cai MH,Liang XY,Wu YQ,et al.Six-week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment:a self-controlled clinical study[J].J Obstet Gynaecol Res,2018,45(2):376-381
• [20]Cai MH,Gao LZ,Liang XY,et al.The effect of growth hormone on the clinical outcomes of poor ovarian reserve patients undergoing in vitro fertilization/intracytoplasmic sperm injection treatment:a retrospective study based on POSEIDON criteria[J].Front Endocrinol (Lausanne),2019,10:775
• [21]Li XL,Wang L,Lv F,et al.The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles:a systematic review and meta-analysis[J].Medicine,2017,96(12):e6443
• [22]Lee YX,Shen MS,Tzeng CR.Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders[J].Front Endocrinol(Lausanne),2019,10:892
• [23]中华医学会内分泌分会．成人生长激素缺乏症诊治专家共识(2020版)[J]．中华内分泌代谢杂志，2020,36(12):995-1002
• [24]Zhu H,Xu Y,Gong F,et al.Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults[J].PloS one,2017,12(10):e0185561
• [25]Safdarian L,Aghahosseini M,Alyasin A,et al.Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders:a randomized study[J].Asian Pac J Cancer Prev,2019,20(7):2033-2037
• [26]Critical evaluation of the safety of recombinant human growth hormone administration:statement from the Growth Hormone Research Society[J].J Clin Endocrinol Metab,2001,86(5):1868-70
• [27]Duffy JM,Ahmad G,Mohiyiddeen L,et al.Growth hormone for in vitro fertilization[J].Cochrane Database Syst Rev,2010,20(1):CD000099
• [28]Allen DB,Backeljauw P,Bidlingmaier M,et al.GH safety workshop position paper:a critical appraisal of recombinant human GH therapy in children and adults[J].Eur JEndocrinol,2016,174(2):1-9